Cheng-Yuan Peng

49PUBLICATIONS
97CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicinePredictive and prognostic markersMajor global burdens of diseaseCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Apr 20, 2026
Absence of steatosis combined with cardiometabolic risk factors confers the highest hepatocellular carcinoma risk in treated chronic hepatitis B.

|Nov 14, 2025
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Yun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee

|Oct 20, 2025
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication.

Wei-Fan Hsu, Ching-Chu Lo, Kuo-Chih Tseng

|Jun 20, 2025
Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan.

Szu-Jen Wang, Te-Sheng Chang, Ching-Chu Lo

|May 24, 2025
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.

Ping-Jen Hu, Pei-Chien Tsai, Chi-Yi Chen

|Feb 21, 2025
Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus Infection.

Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen

Pageof 9

Frequent Collaborators

16 joint publications

Jia-Horng Kao

11 joint publications

Chen-Hua Liu

11 joint publications

Ming-Lung Yu

9 joint publications

Wei-Fan Hsu